In terms of anti-doping regulations, it is worth mentioning that the rules are evolving, as BPC-157 was included in the WADA monitoring/prohibited list in 2022 on a temporary basis
Tirzepatide is administered subcutaneously once weekly and works by activating GIP and GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite
5 Fundamentally, making sure your body has enough malate will keep the TCA cycle working smoothly and ensure your muscles have enough usable energy to keep you moving
This supports the idea that GLP-1 RAs as a class are likely friends rather than foes to erectile function, insofar as they ameliorate the underlying causes of ED
These questions sit at the intersection of medicine, vanity, shame, health, aging, privilege and freedom